关注
Jayesh Desai
Jayesh Desai
Peter MacCallum Cancer Centre, University of Melbourne
在 petermac.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
GD Demetri, AT van Oosterom, CR Garrett, ME Blackstein, MH Shah, ...
The Lancet 368 (9544), 1329-1338, 2006
31992006
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
MJ Overman, R McDermott, JL Leach, S Lonardi, HJ Lenz, MA Morse, ...
The lancet oncology 18 (9), 1182-1191, 2017
25902017
The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity
J Canon, K Rex, AY Saiki, C Mohr, K Cooke, D Bagal, K Gaida, T Holt, ...
Nature 575 (7781), 217-223, 2019
17532019
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
J Tie, Y Wang, C Tomasetti, L Li, S Springer, I Kinde, N Silliman, M Tacey, ...
Science translational medicine 8 (346), 346ra92-346ra92, 2016
13742016
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ...
New England Journal of Medicine 383 (13), 1207-1217, 2020
13352020
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
S Kopetz, A Grothey, R Yaeger, E Van Cutsem, J Desai, T Yoshino, ...
New England Journal of Medicine 381 (17), 1632-1643, 2019
12752019
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
TF Chu, MA Rupnick, R Kerkela, SM Dallabrida, D Zurakowski, L Nguyen, ...
The Lancet 370 (9604), 2011-2019, 2007
12282007
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ...
Cancer 117 (20), 4623-4632, 2011
8342011
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ...
Journal of clinical oncology 33 (34), 4032-4038, 2015
7392015
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, HL Wong, J Roebert, M Christie, M Tacey, R Wong, ...
Annals of Oncology 26 (8), 1715-1722, 2015
6352015
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
CP Raut, M Posner, J Desai, JA Morgan, S George, D Zahrieh, ...
Journal of Clinical Oncology 24 (15), 2325-2331, 2006
5802006
Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer
RN Jorissen, P Gibbs, M Christie, S Prakash, L Lipton, J Desai, D Kerr, ...
Clinical Cancer Research 15 (24), 7642-7651, 2009
4772009
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
J Desai, L Yassa, E Marqusee, S George, MC Frates, MH Chen, ...
Annals of internal medicine 145 (9), 660-664, 2006
4702006
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer
NI Fleming, RN Jorissen, D Mouradov, M Christie, A Sakthianandeswaren, ...
Cancer research 73 (2), 725-735, 2013
3842013
PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors.
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'dwyer, RJ Lee, KB Nolop, ...
Journal of Clinical Oncology 28 (15_suppl), 3534-3534, 2010
3582010
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and …
J Tabernero, A Grothey, E Van Cutsem, R Yaeger, H Wasan, T Yoshino, ...
Journal of Clinical Oncology 39 (4), 273-284, 2021
3512021
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ...
The Lancet 394 (10197), 478-487, 2019
3372019
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents
M Mao, F Tian, JM Mariadason, CC Tsao, R Lemos Jr, F Dayyani, ...
Clinical cancer research 19 (3), 657-667, 2013
3292013
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
J Goldstein, B Tran, J Ensor, P Gibbs, HL Wong, SF Wong, E Vilar, J Tie, ...
Annals of Oncology 25 (5), 1032-1038, 2014
3062014
Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation
J Tie, P Gibbs, L Lipton, M Christie, RN Jorissen, AW Burgess, M Croxford, ...
International journal of cancer 128 (9), 2075-2084, 2011
2722011
系统目前无法执行此操作,请稍后再试。
文章 1–20